about
Reduced bone mass and muscle strength in male 5α-reductase type 1 inactivated miceThe 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseasesSXR, a novel steroid and xenobiotic-sensing nuclear receptorcDNA cloning and characterization of a new human microsomal NAD+-dependent dehydrogenase that oxidizes all-trans-retinol and 3alpha-hydroxysteroidsSRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorderHuman prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasterideMale pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2)The molecular biology, biochemistry, and physiology of human steroidogenesis and its disordersWhy boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiationPharmacology of anabolic steroidsInhibition of human steroid 5beta-reductase (AKR1D1) by finasteride and structure of the enzyme-inhibitor complexThe effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young menCharacterization of brain neurons that express enzymes mediating neurosteroid biosynthesisIdentification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptorActivity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cExpression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinomaMechanisms of resistance in castration-resistant prostate cancer (CRPC)Plasticity of GABAA Receptors during Pregnancy and Postpartum Period: From Gene to FunctionTargeting cancer using cholesterol conjugatesMolecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerAndrogen biosynthesis in castration-resistant prostate cancerCrystal Structure of Human Liver 4-3-Ketosteroid 5 -Reductase (AKR1D1) and Implications for Substrate Binding and CatalysisEvidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasiaIdentification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiencyUnexpected virilization in male mice lacking steroid 5 alpha-reductase enzymesThe effect of finasteride and dutasteride on the growth of WPE1-NA22 prostate cancer xenografts in nude micePreventive and therapeutic efficacy of finasteride and dutasteride in TRAMP miceExpression and regulation of steroid 5 alpha-reductase in the genital tubercle of the fetal ratStimulatory effect of insulin on 5alpha-reductase type 1 (SRD5A1) expression through an Akt-dependent pathway in ovarian granulosa cellsRegulation of prostate 5alpha-reductase-2 gene expression and prostate weight by dietary fat and caloric intake in the ratEffects of dihydrotestosterone on brain mRNA levels of steroid 5alpha-reductase isozymes in early postnatal life of ratExpression of 5α- and 5β-reductase in spinal cord and muscle of birds with different courtship repertoires.Molecular diagnosis of 5α-reductase type II deficiency in Brazilian siblings with 46,XY disorder of sex developmentEffects of sulpiride on mRNA levels of steroid 5alpha-reductase isozymes in prostate of adult rats.Precise quantitation of steroid 5alpha lambda pi eta alpha-reductase type 1 mRNA levels by RT-PCR in female rat liver.Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometryNew developments in the medical management of prostate cancer.Transcriptional regulation of the mouse steroid 5alpha-reductase type II gene by progesterone in brainMedical treatment of benign prostatic hyperplasia.Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.
P2860
Q21135319-36CED6FE-C767-49DB-B303-9A715E365C97Q21285041-6E986FA9-7C19-419C-8B4A-4CEFDFD6A1D3Q22003995-3C8C82ED-B0FE-43EC-9183-9B5D37C33FA2Q24317751-630AC506-5CF5-4F51-AD3F-3A64DD28AF95Q24338882-0C96425F-5197-4F5E-ABF3-2D6B6D67EDEDQ24603802-62C612B8-5208-422A-AAF4-9860E0121348Q24609205-11B3638E-22BC-48FA-85EE-0B1896C24396Q24613957-C56B943E-2E03-4855-A90C-82363FB34E47Q24618043-FFC195EF-CDD4-4C48-9CF4-F16C968F0E3BQ24650695-57521F16-2610-4964-B0A0-58B49FD27CBDQ24658019-C18296B6-5C18-49D0-B8C4-9E36B1C2FF7FQ24658075-102242E5-AD9F-41D9-89CE-BC9C03AD3E0FQ24676534-C979B4C2-8599-45A8-8399-C691B58ED48EQ24679336-66071175-5FDB-4FAF-9965-72C21B4E1ED6Q24794475-F979A52A-FD38-4674-85AD-182011BFF31AQ24804238-12E44837-AA86-49E9-9107-335594865C33Q26774221-7C753FAB-2B06-422B-820B-7B57739FF73EQ26785771-3E74E528-7319-4535-97B8-9139B02F3A70Q26860103-5491BDC5-1835-49A8-8111-BBF6E89138C5Q27024775-870B0D3A-B779-4147-8380-D1076A68CF3CQ27026044-F2FA768F-2954-48B6-A4F8-E1D148244348Q27650311-FD40D02E-C885-4016-91B2-6DBB80F336A1Q28077954-BA63D625-F9F9-417A-B0D7-2479FB31E62BQ28138689-7FC9BB26-F102-45C8-91C0-241CB8371EDEQ28362109-7C049772-A3F7-4579-A60C-3C96800CBB5EQ28478721-B7048736-0A6E-4127-8A7A-2F52D4F477E4Q28534518-056419B6-ADE8-472D-BFB0-C4849C8F6ADCQ28565644-C951E022-87AF-4DF0-969C-F6CCA91978C4Q28567265-4093067D-1076-4439-B5C9-7DC1E951717EQ28571185-8433A137-EEF2-433B-8610-FEED6243F38FQ28577574-0938A455-3D98-4003-9567-867624737175Q30381562-34155D29-C048-4586-9326-CCA3E3506789Q30412142-E3CA3DA7-09E9-4F61-BD09-070F0DBCCEBEQ30842447-7C45DAB7-DCBD-4BFD-B7F7-4FFEF786FFACQ31119437-4D661C99-B419-4BAD-B466-F8C8AAFFD213Q33463058-05F6EA53-D630-47A6-BE04-572C9721DC48Q33566738-D991650C-2200-4018-924D-9D70B7757529Q33587653-0B339153-FEA0-49CB-9A70-9F9022C002EDQ33588534-70652164-8F46-43DC-8BBE-B4E309690798Q33623428-8AF7C9D6-3D9D-4253-A33B-3C149490612B
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Steroid 5 alpha-reductase: two genes/two enzymes.
@en
type
label
Steroid 5 alpha-reductase: two genes/two enzymes.
@en
prefLabel
Steroid 5 alpha-reductase: two genes/two enzymes.
@en
P1476
Steroid 5 alpha-reductase: two genes/two enzymes.
@en
P2093
P356
10.1146/ANNUREV.BI.63.070194.000325
P577
1994-01-01T00:00:00Z